Medicine details

ImageAsmolex L
NameAsmolex L
DosageTablet
Generic NameLevosalbutamol
Classes Respiratory Agent
Antiasthmatic
Antiasthmatic
Diseases Asthma
Bronchitis
Chronic Obstructive Pulmonary Disease (COPD)
Respiratory Disease
CompanyAristopharma Limited

Drug Package Details

Strength1 mg
Storage Condition
Origin CountryBangladesh
Commercial Pack100
Price per pack79.72
Cost per pack70.15
Package unit10 tabs strip
Price per unit0.80
Cost per unit0.70
Discount0
Coupon
Remarks

Levosalbutamol

Levosalbutamol is beta 2 adrenergic receptor agonist. Beta 2 receptors are predominantly located in the trachea and air ways. Activation of the receptor causes relaxation of smooth muscles which causes bronchodialation.

Levosalbutamol is indicated in-

  • Asthma
  • Bronchospasm
  • COPD
  • Exercise-Induced Bronchospasm Prevention
  • Adult and Pediatric Asthma: The usual dosage for adults and children 4 years of age and older for treatment of acute episodes of bronchospasm or prevention of asthmatic symptoms is 2 inhalations repeated every 4 to 6 hours; in some patients, 1 inhalation every 4 hours may be sufficient. More frequent administration or a greater number of inhalations are not advised.
  • Exercise-Induced Bronchospasm Prevention: The usual dosage for adults and children 4 years and older is 2 inhalations 15 to 30 minutes before exercise.
How to administer Inhaler

Levosalbutamol can cause the following side effects-

  • Throat irritation
  • Nose irritation
  • Ear irritation
  • Upper respiratory inflammation
  • Lower respiratory Viral respiratory infection
  • Cough
  • As with all sympathomimetic amines, Levosalbutamol should be used with caution in patients with cardiovascular disorders, particularly coronary insufficiency, hypertension, and cardiac arrhythmia; in patients with convulsive disorders, hyperthyroidism, or diabetes mellitus; and in patients who are unusually responsive to sympathomimetic amines.
  • Individual patients have experienced clinically significant changes in systolic and diastolic blood pressure, which could be expected in some patients after using any beta-adrenergic bronchodilator.
  • Large intravenous Levosalbutamol doses have been reported to aggravate preexisting diabetes and ketoacidosis.
  • Levosalbutamol, like other beta-agonists, can cause significant hypokalemia in some patients, possibly through intracellular shunting, which can lead to adverse cardiovascular effects. The decrease is usually transient and does not necessitate supplementation.

Contraindication

Contraindicated in patients hypersensitive to any component of the medication.